XML 20 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income (Loss) $ (76,365) $ 1,518,681
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships (249,099) (1,751,662)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 82,995 (28,600)
Decrease (Increase) in other assets 69,038 (14,660)
(Decrease) Increase in accounts payable affiliates 317,783 6,512
Net cash (used in) provided by operating activities 144,352 (269,729)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 247,315 1,664,062
Net cash provided by investing activities 247,315 1,664,062
Cash flows from financing activities:    
Distributions 0 (1,500,000)
Net cash used in financing activities 0 (1,500,000)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 391,667 (105,667)
Cash and cash equivalents, beginning 5,463,659 2,049,777
Cash and cash equivalents, ending 5,855,326 1,944,110
Series Fifteen
   
Cash flows from operating activities:    
Net income (Loss) (59,828) (52,322)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships 0 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 (27,600)
Decrease (Increase) in other assets 69,038 0
(Decrease) Increase in accounts payable affiliates 54,828 14,737
Net cash (used in) provided by operating activities 64,038 (65,185)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 0
Net cash provided by investing activities 0 0
Cash flows from financing activities:    
Distributions 0 0
Net cash used in financing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 64,038 (65,185)
Cash and cash equivalents, beginning 299,446 278,978
Cash and cash equivalents, ending 363,484 213,793
Series Sixteen
   
Cash flows from operating activities:    
Net income (Loss) (30,903) 29,785
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships (79,784) (132,105)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 10,000 15,000
Decrease (Increase) in other assets 0 0
(Decrease) Increase in accounts payable affiliates 109,870 (82,103)
Net cash (used in) provided by operating activities 9,183 (169,423)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 78,000 132,105
Net cash provided by investing activities 78,000 132,105
Cash flows from financing activities:    
Distributions 0 0
Net cash used in financing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 87,183 (37,318)
Cash and cash equivalents, beginning 416,806 416,557
Cash and cash equivalents, ending 503,989 379,239
Series Seventeen
   
Cash flows from operating activities:    
Net income (Loss) 122,498 22,198
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships (169,315) (105,177)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 72,995 1,600
Decrease (Increase) in other assets 0 (14,660)
(Decrease) Increase in accounts payable affiliates 86,302 102,691
Net cash (used in) provided by operating activities 112,480 6,652
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 169,315 17,577
Net cash provided by investing activities 169,315 17,577
Cash flows from financing activities:    
Distributions 0 0
Net cash used in financing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 281,795 24,229
Cash and cash equivalents, beginning 328,413 199,038
Cash and cash equivalents, ending 610,208 223,267
Series Eighteen
   
Cash flows from operating activities:    
Net income (Loss) (70,247) (36,218)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships 0 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 7,000
Decrease (Increase) in other assets 0 0
(Decrease) Increase in accounts payable affiliates 66,783 (28,813)
Net cash (used in) provided by operating activities (3,464) (58,031)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 0
Net cash provided by investing activities 0 0
Cash flows from financing activities:    
Distributions 0 0
Net cash used in financing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (3,464) (58,031)
Cash and cash equivalents, beginning 293,045 347,309
Cash and cash equivalents, ending 289,581 289,278
Series Nineteen
   
Cash flows from operating activities:    
Net income (Loss) (37,885) 1,555,238
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of (Income) from Operating Partnerships 0 (1,514,380)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 (24,600)
Decrease (Increase) in other assets 0 0
(Decrease) Increase in accounts payable affiliates 0 0
Net cash (used in) provided by operating activities (37,885) 16,258
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 1,514,380
Net cash provided by investing activities 0 1,514,380
Cash flows from financing activities:    
Distributions 0 (1,500,000)
Net cash used in financing activities 0 (1,500,000)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (37,885) 30,638
Cash and cash equivalents, beginning 4,125,949 807,895
Cash and cash equivalents, ending $ 4,088,064 $ 838,533